483
Chartwell Pharmaceuticals LLCFDA 483 - Chartwell Pharmaceuticals LLC - May 24, 2023
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
Chartwell Pharmaceuticals LLC, a drug manufacturer in Congers, NY, was inspected by the FDA and received six observations. The inspection revealed significant deficiencies in stability data, quality control unit procedures, employee training, production hold times, and facility/equipment readiness for new product manufacturing. These issues indicate a broad lack of adherence to good manufacturing practices.
Open in Dashboard
ID · de95b640-b564-4faf-9ca2-063958f30e33